ABSTRACT In 16 patients with recent myocardial infarction (3 to 12 week old) and with large left ventricular thrombi systemic thrombolysis with urokinase was performed. Left ventricular thrombi were diagnosed by two-dimensional echocardiography; in all patients the mural thrombus was located in the area of recent myocardial infarction. Each of three patients suffered an embolic episode before the initiation of thrombolytic therapy and the episode caused a stroke in one. Urokinase was infused intravenously at a rate of 60.000 U/hr for 2 to 8 days in combination with intravenous heparin (200 units/kg x 12 hr). Left ventricular thrombi were successfully lysed in 10 of 16 patients, as determined by two-dimensional echocardiography. In four of the six remaining patients only partial thrombolysis was achieved and in two thrombolytic treatment failed. There was no evidence of embolic events during thrombolysis in any of the 16 patients. The success of thrombolysis seemed to depend on the age of the thrombus: the thrombus was dissolved in eight of nine patients undergoing thrombolysis within 4 weeks of the acute myocardial infarction vs in two of seven patients receiving treatment later (p .057). The presence of a left ventricular aneurysm or depressed left ventricular function also appeared to reduce the likelihood of successful thrombolysis. All patients were discharged on oral anticoagulants. At 6 months follow-up (n = 9) no recurrence of left ventricular thrombus was found. These results show that left ventricular thrombi can be safely lysed by intravenous urokinase. However, for better definition of the risk and benefit of this new therapy further investigation is necessary. Circulation 72, No. 1, 112-118, 1985. MURAL LEFT VENTRICULAR thrombi are common in patients with acute myocardial infarction. "As calculated from autopsy reports, the incidence of mural thrombi in patients who died of myocardial infarction ranged from 14% to 68%.5-9 Thrombi are more common in patients with large than in those with small infarcts." 2.4 10 Although a mural thrombus adheres to the endocardium, it can produce systemic emboli. The incidence of embolism varies considerably depending on whether the mural thrombus is detected during life or at autopsy. Autopsy studies5 8 1104 have reported a 22% to 64% incidence of embolism in patients with cardiac thrombus, whereas in clinical studies, in which the left ventricular thrombus was diagnosed by angiography, two-dimensional echocardiography, or at operation, a lower incidence (0 to 36%) has been described.2 4, 15-22 In one study, half of the emboli were cerebral.23
MURAL LEFT VENTRICULAR thrombi are common in patients with acute myocardial infarction. "As calculated from autopsy reports, the incidence of mural thrombi in patients who died of myocardial infarction ranged from 14% to 68%.5-9 Thrombi are more common in patients with large than in those with small infarcts." 2.4 10 Although a mural thrombus adheres to the endocardium, it can produce systemic emboli. The incidence of embolism varies considerably depending on whether the mural thrombus is detected during life or at autopsy. Autopsy studies5 8 1104 have reported a 22% to 64% incidence of embolism in patients with cardiac thrombus, whereas in clinical studies, in which the left ventricular thrombus was diagnosed by angiography, two-dimensional echocardiography, or at operation, a lower incidence (0 to 36%) has been described. 2 4, 15-22 In one study, half of the emboli were cerebral. 23 Left ventricular thrombi are commonly found by two-dimensional echocardiography in patients in the early stages of acute myocardial infarction, especially those with an extensive anterior infarction.'. -4. 92^4-28 However, no generally accepted therapy for patients with left ventricular thrombi has been found. Some authors advise use of anticoagulation2 29 30 or antithrombotic29 30 therapy in the presence of a left ventricular thrombus; in some patients with large, protruding thrombi surgery is recommended because of the high risk of embolization.
In this report, thrombolytic therapy with urokinase as an alternative therapeutic method is described in a series of 16 patients with large, protruding left ventricular thrombi developing early after infarction.
Methods
Patients. In 16 patients (age 40 to 69 years) with left ventricular thrombi systemic thrombolysis with urokinase was performed. The clinical characteristics of the patients are summarized in table 1. All patients had their first myocardial infarction 3 weeks to 3 months before study entry. Selection criteria for inclusion in the study were (1) large, protruding left ventricular thrombi located in the area of myocardial infarction, (2) time after acute myocardial infarction of 3 weeks to 3 months, and (3) no contraindications to systemic thrombolytic therapy with urokinase.
Immediately before initiation of thrombolytic therapy five patients were on heparin (three on low-dose heparin [100 units/ kg body weight sc every 12 hr], two on full-dose heparin [200 Three weeks after bypass surgery and while still on a full dose of heparin, the patient experienced deep-vein thrombosis resulting in massive swelling of the right leg. To resolve the venous thrombosis intravenous urokinase therapy was initiated. To our surprise, not only the venous thrombosis, but also the left ventricular thrombus had disappeared after 7 days of therapy; there was no evidence of systemic or pulmonary embolization.
In a next step we performed intravenous thrombolysis in three patients who had a large mobile left ventricular thrombi despite Vol. 72, No. 1, July 1985 heparin therapy and who were considered candidates for surgical thrombectomy. Because two of the patients had undergone bypass surgery in the weeks before and had poor left ventricular function, reoperation carried a major risk. In these patients thrombolysis resulted in complete dissolution of the left ventricular thrombus with no complications.
After these positive experiences we were encouraged to perform thrombolysis in patients with large, mobile left ventricular thrombi likely to embolize. In most of the patients these had developed despite use of anticoagulant therapy.
Two-dimensional echocardiography. Two-dimensional echocardiograms were obtained with a Diasonics 3400 R phased-array sector scanner. A standard two-dimensional echocardiographic examination consisting of parasternal short-and long-axis views and apical two-and four-chamber views was performed in all patients; additionally, multiple tangential views from the apex were recorded to measure maximal thrombus size.
In all patients thrombus size was such that the two-dimensional echocardiographic study was considered definitely positive for left ventricular thrombus by three different observers.
A thrombus was defined as an echo-dense mass adjacent to an asynergic left ventricular segment protruding into the left ventricular cavity. As described by Stratton An ancurysm was defined echocardiographically as a wellcircumscribed bulging segment of myocardium demonstrating dyskinesis or akinesis.
Global left ventricular ejection fraction was estimated from the apical two-and four-chamber view by tracing the endocardium of the left ventricle (excluding the left ventricular throm bus) at end-diastole (peak R wave) and end-systole (smallest left ventricular area in both views) with a Philips light-pen unit. Global ejection fraction was calculated separately for the twoand four-chamber views; the average between the two measurements was used in the analysis. A significant left ventricular dysfunction was defined as a global cjection fraction of less than 40%.
Two dimensional echocardiographic examnination was performed before starting thrombolytic treatment, every day during intravenous urokinase therapy, and 2 days and wcek after termination of thrombolytic therapy.
Follow-up studies by two-dimensional echocardiography were petformed 3, 6, and 12 months after thrombolysis.
99Tc-platelet imaging. Eight patients underwent 99111Tc- On follow-up, nine of the 10 patients in whom thrombolysis was successful were restudied by twodimensional echocardiography 6 months after treatment. In no case was there evidence of reoccurrence of thrombus.
The follow-up to this point dates back 12 months in five patients: reexamination by two-dimensional echocardiography in this subset also did not reveal reformation of left ventricular thrombus.
Determination of successful thrombolysis. On retrospective analysis patient data revealed some differences concerning the efficacy of thrombolytic therapy. The chances for successful thrombolysis were best when the age of the thrombus was 4 weeks or less. In eight of nine patients undergoing thrombolytic therapy 3 to 4 weeks after acute myocardial infarction left ventricular thrombi were successfully dissolved by systemic urokinase. However, thrombolysis was successful in only two of seven patients with a myocardial infarction between 5 and 12 weeks old (p = .057).
Left ventricular ejection fractioni estimated by twodimensional echocardiography was moderately or severely depressed in all but one of the six patients in whom thrombolysis was partial or did not occur (36 ± 8%, n 6); only four of 10 patients in whom thrombolysis was successful had evidence of significant left ventricular dysfunction, whereas the remaining six patients had a normal or mildly depressed left ventricular ejection fraction (46 -+-10%, n = 10).
In each of five patients a left ventricular aneurysm was demonstrated by two-dimensional echocardiography; four patients had a left ventricular apical aneurysm after acute myocardial infarction and one patient had a posterior wall aneurysm. In all four patients with an apical aneurysm thrombolytic therapy was unsuccessful, in contrast to the case in the one patient with a posterior wall aneurysm in whom thrombolysis was successful.
Immediately preceding thrombolytic therapy 99t1Tc-platelet imaging was performed in eight patients. At the time the platelet scan was performed four patients were on anticoagulants, three were on dicumarol, and one was on full-dose heparin. Four patients received Five patients had negative platelet scans; despite the failure to demonstrate thrombus activity by this technique thrombolysis was successful in three patients. Additionally, successful thrombolysis was achieved in one patient with an equivocal scan.
Complications. During thrombolytic therapy and at follow-up there was no clinical evidence of embolic events in any of 16 patients. One patient developed hematuria during thrombolytic therapy, which required discontinuation of the therapy after 5 days of treatment. At that time, the left ventricular thrombus had been partially dissolved. Reexamination by twodimensional echocardiography 1 week and 6 months later revealed no further reduction in thrombus size. Another patient developed only mild hematuria after 3 days of therapy with intravenous urokinase. Thrombolytic treatment was continued and resulted in complete thrombolysis of a large left ventricular thrombus that initially protruded into the left ventricular outflow tract.
Discussion
Systemic embolic are a well-known complication of mural thrombi in patients with transmural myocardial infarction. 4 15 20-22 Since left ventricular mural thrombi can now easily be diagnosed by two-dimensional echocardiography,' 2, 22. 24 patients at risk of systemic embolism can be identified. The question arises, however, as to how these patients should be treated to prevent embolization. Long-term anticoagulation is considered by many a method of diminishing the risk of embolization after myocardial infarction.3'-3 However, to our knowledge no prospective studies are available demonstrating a lower incidence of emboli with anticoagulant therapy in patients with proven left ventricular thrombi. Anticoagulation is thought to prevent further apposition of the thrombus by enhancing organization and endothelialization. Edwards,36 however, reports that thrombi larger than 5 mm are rarely organized, regardless of their age.
Recently published data suggest that full-dose heparin or warfarin anticoagulation may lead to thrombus resolution in the setting of acute myocardial infarction. 2' 3, 29 30 According to the report of Visser et In seven of 10 patients on coumarin therapy Tramarin et al.9 observed the disappearance of left ventricular thrombi within 5 weeks after myocardial infarction.
However, in contrast to our patient population, the patients of Tramarin et al. did not begin anticoagulant therapy until their left ventricular thrombi were observed by two-dimensional echocardiography. Since the left ventricular thrombi in our patients had developed despite anticoagulation in the majority of cases, it appears unlikely that they would have been dissolved by the same medication.
If recurrent systemic emboli develop despite adequate anticoagulation surgical removal of the thrombus becomes necessary. This may also be true for large protruding and mobile thrombi that are likely to embolize.371-9
In this report we introduce an alternative method of treatment of mural left ventricular thrombi, i.e., systemic thrombolysis with urokinase. By use of this method left ventricular thrombi less than 3 months old that were adherent to an area of myocardial infarction were dissolved in two of three of patients. All patients were fully heparinized during the acute stage of myocardial infarction, i.e., they received heparin for at least 72 hr or until they were ambulatory. Half of the patients (eight of 16) were on oral anticoagulants or were fully heparinized before thrombolysis.
Left ventricular thrombi of patients in this study were remarkably large, with an average maximal diameter of 3.7 + 1.2 cm. Nevertheless, it took only several days of thrombolytic therapy to completely resolve them. Although some of the thrombi were attached to the left ventricular wall with a stalk, no emboli occurred during or after thrombolysis independent of the result. During a follow-up period of 6 months, no recurrence of thrombus or embolism was noted.
These data suggest that intravenous lysis with urokinase is an effective and probably safe method of dissolving large left ventricular thrombi. In our opinion, lysis should be attempted (I) in patients being considered for surgical removal of thrombus, (2) in patients with peripheral recurrent emboli despite adequate anticoagulation, and (3) possibly in patients with large protruding thrombi likely to embolize.
The potential benefit of thrombolysis has to be weighed against the risks of urokinase-induced bleeding and embolization.40 41 
